Merck Expands Outsourcing With Zhejiang Huahai For HIV Finished Product Manufacturing
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's leading contract manufacturing company and API provider Zhejiang Huahai announced March 8 that the company has reached a drug supply agreement with Merck to produce finished drugs for the next several years
You may also be interested in...
China's State FDA Imposes New Regulatory Requirements On CMOs And Third-party Contracts
SHANGHAI - In a bid to prevent the export of counterfeit medicines, China is tightening its supervision of contract manufacturing organizations doing work for overseas drug makers. To that end, China's State FDA recently issued a notice on new rules governing cross-border contract manufacturing
China's State FDA Imposes New Regulatory Requirements On CMOs And Third-party Contracts
SHANGHAI - In a bid to prevent the export of counterfeit medicines, China is tightening its supervision of contract manufacturing organizations doing work for overseas drug makers. To that end, China's State FDA recently issued a notice on new rules governing cross-border contract manufacturing
New Approaches To Innovation Needed To Reach Globe's Poor At The "Bottom Of The Pyramid" - And To Fend Off Emerging Competitors Around The World
CAMBRIDGE, Mass. - Life science companies looking to provide healthcare solutions to the poorer, "bottom of the pyramid" - a population reaching more than 600 million people in India alone - should focus on business model innovation as much as on innovative products, according to delegates at the U.S.-India Chamber of Commerce biopharmaceutical and healthcare summit in Cambridge, Mass